Connect Biopharma vs iBio
CNTB and IBIO side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CNTB and IBIO compare
iBio grew revenue faster over the last twelve months (115% versus 50.3% for Connect Biopharma).
Connect Biopharma keeps more of each dollar of sales as profit, with a net margin of −2336% compared with −3244% at iBio.
iBio scores higher on the StockData Score (9 against 6 for Connect Biopharma), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CNTB | IBIO |
|---|---|---|
| Size and price | ||
| Market cap | – | $47.1M |
| Share price | $0.677 | $0.732 |
| Change, 1 year | −57.9% | −41.5% |
| Change, 5 years | −86.8% | −99.8% |
| Beta (5Y) | 0.53 | 1.12 |
| Employees | – | 23 |
| StockData Score | ||
| Total score | 6 | 9 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 1 | 1 |
| Performance score | 0 | 2 (better) |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 43.8× |
| P/B | – | 0.6× |
| FCF yield | – | −58.6% |
| Growth | ||
| Revenue growth (TTM) | 50.3% | 115% (better) |
| Revenue growth, 5Y average | – | −46.9% |
| Profitability | ||
| Operating margin | −2384% (better) | −3491% |
| Net margin | −2336% (better) | −3244% |
| FCF margin | −2053% (better) | −2566% |
| Return on equity | −141% | −51.8% (better) |
| Return on invested capital | – | −728% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 2.37 | 9.48 (better) |
| Altman Z-score | – | −3.49 |
| Piotroski F-score | 1 | 4 (better) |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 22.1% | 54.0% |
| Held by insiders | 31.6% | 0.47% |
| Insider net buying, 12 months | $4.4M (better) | $98.1K |
| Short interest, % of float | – | 6.3% |
Go deeper
- CNTB stock overview
- CNTB income statement
- CNTB valuation and score
- IBIO stock overview
- IBIO income statement
- IBIO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.